What is the official website of Fosun Pharma ?

The official website of Fosun Pharma is http://www.fosunpharma.com/.

What is Fosun Pharma's cybersecurity risk score?

Fosun Pharma has an AI-generated cybersecurity risk score of 764 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Fosun Pharma experienced?

According to Rankiteo, Fosun Pharma currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Fosun Pharma been affected by any supply chain cyber incidents ?

According to Rankiteo, Fosun Pharma has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Fosun Pharma have SOC 2 Type 1 certification ?

According to Rankiteo, Fosun Pharma is not certified under SOC 2 Type 1.

Does Fosun Pharma have SOC 2 Type 2 certification ?

According to Rankiteo, Fosun Pharma does not hold a SOC 2 Type 2 certification.

Does Fosun Pharma comply with GDPR ?

According to Rankiteo, Fosun Pharma is not listed as GDPR compliant.

Does Fosun Pharma have PCI DSS certification ?

According to Rankiteo, Fosun Pharma does not currently maintain PCI DSS compliance.

Does Fosun Pharma comply with HIPAA ?

According to Rankiteo, Fosun Pharma is not compliant with HIPAA regulations.

Does Fosun Pharma have ISO 27001 certification ?

According to Rankiteo,Fosun Pharma is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Fosun Pharma operate in ?

Fosun Pharma operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Fosun Pharma have ?

Fosun Pharma employs approximately 5,087 people worldwide.

Does Fosun Pharma own any subsidiaries ?

Fosun Pharma presently has no subsidiaries across any sectors.

How many LinkedIn followers does Fosun Pharma have ?

Fosun Pharma's official LinkedIn profile has approximately 26,633 followers.

What is the NAICS classification code for Fosun Pharma ?

Fosun Pharma is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Fosun Pharma have a Crunchbase profile ?

Yes, Fosun Pharma has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/fosun-pharmaceutical.

Does Fosun Pharma have a LinkedIn profile ?

Yes, Fosun Pharma maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/fosunpharma.

How many cybersecurity incidents has Fosun Pharma experienced ?

As of September 15, 2026, Rankiteo reports that Fosun Pharma has not experienced any cybersecurity incidents.

How many peer or competitor companies does Fosun Pharma have ?

Fosun Pharma has an estimated 5,761 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Fosun Pharma

Boost Score +25 with badge (5 left)

764

/1000

Fair

789

/1000

Fair

Fosun Pharma Vendor Cyber Rating & Cyber Score

fosunpharma.com

cb in

Add Your Compliance Badge

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; SSE: 600196, HKEX: 02196) is a leading innovation-driven global healthcare company operating in the fields of pharmaceuticals, medical devices & diagnostics, and healthcare services. Through its strategic alliance with Sinopharm Group Co., Ltd., Fosun Pharma further extends its capabilities in pharmaceutical commerce. Over the past 30 years since its establishment, Fosun Pharma has maintained deep roots in China while strategically expanding its global presence. The company has been actively implementing its “4IN” strategy -Innovation, Internationalization, Intelligentization, and Integration, with core business operations now spanning major overseas markets

Fosun Pharma

Fosun Pharma CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Fosun Pharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Fosun Pharma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fosun Pharma in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Fosun Pharma in 2026.

Incident Types Fosun Pharma vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fosun Pharma in 2026.

Incident History - Fosun Pharma (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Fosun Pharma Subsidiaries

Fosun Pharma

Pharmaceutical Manufacturing

Website: http://www.fosunpharma.com/

Company Size: 5,087

Gland Pharma LimitedPharmaceutical Manufacturing

Fosun 复星Consumer Services

Club MedHospitality

Club Med PropertyImmobilier

Meetings & Events by Club MedEvents Services

Club Med Meetings & Events (AU & NZ)Events Services

Millennium bcpBanking

Rio Bravo InvestimentosInvestment Management

Peak ReInsurance

The Bund Finance CenterLeasing Non-residential Real Estate

Alma LasersMedical Equipment Manufacturing

FemiLiftMedical Equipment Manufacturing

BeautiFill made by LipoLifeMedical Device

Alma Lasers North AmericaMedical Equipment Manufacturing

Alma Lasers GmbHMedical Device

FF OpsCoRetail Luxury Goods and Jewelry

复星保德信人寿保险有限公司Insurance

Fosun HiveReal Estate

Breas MedicalMedical Equipment Manufacturing

ERS Congress 2019Medical Device

HenliusBiotechnology Research

Henlius USA Inc.Biotechnology Research

Guilin Pharmaceutical Co., Ltd.Pharmaceutical Manufacturing

Loading…

Fosun Pharma Similar Companies

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

Loading…

NEWS

Fosun Pharma CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

September 26, 2025 07:00 AM

Trump's New 100% Tariff On Patented Drugs Triggers Slide In Asian Pharma Stocks

Trump said the tariffs will go into effect on October 1, but the levy won't apply to companies that have started building manufacturing...

Read Article

June 06, 2022 07:00 AM

China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers

Fosun Pharmaceutical, the pharmaceutical arm of investment firm Fosun International controlled by China billionaire Guo Guangchang, will pay up to S$217.6...

Read Article

October 22, 2020 07:00 AM

Dr. Reddy's shuts 'key' plants worldwide after potential cyberattack hits COVID work

Dr. Reddy's Laboratories isolated all data center services as a preventive measure after detecting a breach, the company said Thursday.

Read Article

March 17, 2017 07:00 AM

PBM Sells Interest in Breas Medical to Shanghai Fosun Pharmaceutical

PBM Capital Group said it sold a majority interest in Breas Medical Group to Shanghai Fosun Pharmaceutical (Group) Co., a publicly traded...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-91201

SUMMARY

DocsGPT through 0.20.0 posts OAuth connector session tokens to a wildcard target origin in the callback-status endpoint without validating sender origin. Attackers can obtain session tokens and provider account emails by acting as window.opener during OAuth authorization, then use tokens to disconnect victims' cloud storage connectors.

Published

Date2026-09-14

Updated

Date2026-09-14

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-91200

SUMMARY

DevSpace through 6.3.21 fails to reject parent-directory segments in tar entry names from the in-pod sync stream. Attackers operating a malicious container can stream tar entries with traversal sequences to write arbitrary files on the developer workstation, enabling code execution.

Published

Date2026-09-14

Updated

Date2026-09-14

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

CVE-2026-91199

SUMMARY

Refly through 1.1.0 contains a server-side request forgery vulnerability in the POST /v1/misc/scrape endpoint that fetches caller-supplied URLs without validating the scheme, host, or resolved address. Authenticated attackers can make the backend issue requests to loopback, private, and link-local addresses including cloud metadata services to read page titles and descriptions of internal resources.

Published

Date2026-09-14

Updated

Date2026-09-14

RISK INFORMATION (Score: 5)

cvss3

Base Score: 5.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:N/A:N

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.1

REFERENCES

CVE-2026-91198

SUMMARY

GrowthBook through 5.0.1 returns unredacted fact table definitions including raw warehouse SQL in payloads served by unauthenticated public report and experiment endpoints. Attackers with knowledge of a publicly shared report or experiment identifier can read internal data warehouse query text, schema, table names, filter values and datasource identifiers.

Published

Date2026-09-14

Updated

Date2026-09-14

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-91197

SUMMARY

Flowable flowable-engine through 8.0.0 contains an XML external entity injection vulnerability in ProcessDiagramLayoutFactory.parseXml() that fails to disable external entity resolution when parsing deployed BPMN resources. Attackers with process deployment privileges can embed DOCTYPE declarations with external entities in BPMN files to read arbitrary local files or trigger requests to internal network endpoints when diagram layout is computed.

Published

Date2026-09-14

Updated

Date2026-09-14

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Fosun Pharma Vendor Cyber Rating & Cyber Score

Fosun Pharma A.I CyberSecurity Scoring

Fosun Pharma CyberSecurity News & History

Fosun Pharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Fosun Pharma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Fosun Pharma vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Fosun Pharma (X = Date, Y = Severity)

Fosun Pharma Subsidiaries

Fosun Pharma

Fosun Pharma Similar Companies

Novo Nordisk

Sandoz

Glenmark Pharmaceuticals

Ipca Laboratories Limited

Merck Group

MACLEODS PHARMACEUTICALS LTD.

Astellas Pharma

Cipla

Servier

Fosun Pharma CyberSecurity News

Trump's New 100% Tariff On Patented Drugs Triggers Slide In Asian Pharma Stocks

China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers

Dr. Reddy's shuts 'key' plants worldwide after potential cyberattack hits COVID work

PBM Sells Interest in Breas Medical to Shanghai Fosun Pharmaceutical

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Fosun Pharma CyberSecurity News & History

Fosun Pharma Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Fosun Pharma

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Fosun Pharma vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Fosun Pharma (X = Date, Y = Severity)

Fosun Pharma Subsidiaries

Fosun Pharma

Fosun Pharma Similar Companies

Novo Nordisk

Sandoz

Glenmark Pharmaceuticals

Ipca Laboratories Limited

Merck Group

MACLEODS PHARMACEUTICALS LTD.

Astellas Pharma

Cipla

Servier

Fosun Pharma CyberSecurity News

Trump's New 100% Tariff On Patented Drugs Triggers Slide In Asian Pharma Stocks

China’s Fosun Pharma Invests $158 Mln For 60% Stake In Singapore Cancer Treatment Centers

Dr. Reddy's shuts 'key' plants worldwide after potential cyberattack hits COVID work

PBM Sells Interest in Breas Medical to Shanghai Fosun Pharmaceutical

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo